Corbus Pharmaceuticals (NASDAQ:CRBP) Upgraded by StockNews.com to Sell Rating
Corbus Pharmaceuticals (NASDAQ:CRBP – Get Free Report) was upgraded by equities research analysts at StockNews.com to a “sell” rating in a report released on Thursday. Several other brokerages also recently commented on CRBP. Piper Sandler initiated coverage on shares of Corbus Pharmaceuticals in a research report on Monday, December 2nd. They set an “overweight” rating […]
Corbus Pharmaceuticals (NASDAQ:CRBP – Get Free Report) was upgraded by equities research analysts at StockNews.com to a “sell” rating in a report released on Thursday. Several other brokerages also recently commented on CRBP. Piper Sandler initiated coverage on shares of Corbus Pharmaceuticals in a research report on Monday, December 2nd. They set an “overweight” rating […]
